Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregnenolone for Cocaine Use Disorder
NCT03953612Phase 1Completed
- Sponsor
- Yale University
- Start
- Mar 2019
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of pregnenolone in cocaine use disorder (CUD) (3 arms), sponsored by Yale University. Primary endpoint: Craving Change in Stress and Cue Relative to Neutral at 2 weeks. Started Mar 2019; status: completed.
02
Drugs
pregnenolone
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on NCT03953612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03953612.